HB 1239
Pub
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
- Tennessee
- House / Assembly
- Introduced Feb 6, 2025
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
27 actions-
Pub. Ch. 295
-
Effective date(s) 07/01/2025
-
Signed by Governor.
-
Transmitted to Governor for his action.
-
Signed by Senate Speaker
-
Signed by H. Speaker
-
Enrolled; ready for sig. of H. Speaker.
-
H. adopted am. (Amendment 1 - HA0252)
-
Sponsor(s) Added.
-
Passed H., as am., Ayes 92, Nays 1, PNV 0
-
Engrossed; ready for transmission to Sen.
-
Received from House, Passed on First Consideration
-
Senate substituted House Bill for companion Senate Bill.
-
Amendment withdrawn. (Amendment 1 - SA0095)
-
Passed Senate, Ayes 27, Nays 4
-
H. Placed on Regular Calendar for 4/7/2025
-
Placed on cal. Calendar & Rules Committee for 4/3/2025
-
Rec. for pass. if am., ref. to Calendar & Rules Committee
-
Placed on cal. Health Committee for 4/1/2025
-
Action def. in Health Committee to 4/1/2025
-
Rec for pass if am by s/c ref. to Health Committee
-
Placed on cal. Health Committee for 3/25/2025
-
Placed on s/c cal Health Subcommittee for 3/19/2025
-
P2C, ref. to Health Committee
-
Assigned to s/c Health Subcommittee
-
Intro., P1C.
-
Filed for introduction